Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Enrolling by invitation · NCT07209332 · Registry updated 2026-03-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Enrolling by invitation | Phase 2 | 2026-03-06 | NCT07209332 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Wave Life Sciences USA, Inc. | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Istiklal Hospital/ Clinical Research Unit | Amman | Jordan | 2 |
| Oxford Children's Hospital, Oxford University Hospitals NHS Foundation Trust | Headington | United Kingdom | 2 |
| The Specialty Hospital (TSH)/ Advanced Clinical Center | Amman | Jordan | 2 |